Fabbro, D <br/><br/>
PKC412--a protein kinase inhibitor with a broad therapeutic potential.  [electronic resource] 

 -  Anti-cancer drug design  Feb 2000 
 - 17-28 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0266-9536 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiogenesis Inhibitors--pharmacology<br/>Animals<br/>Blood Proteins--metabolism<br/>Cell Cycle--drug effects<br/>Clinical Trials, Phase I as Topic<br/>Enzyme Inhibitors--metabolism<br/>Humans<br/>Mice<br/>Neoplasms--drug therapy<br/>Protein Binding<br/>Protein Kinase C--antagonists & inhibitors<br/>Staurosporine--analogs & derivatives<br/>Tumor Cells, Cultured